28
Those prescribed oxybutynin hydrochloride, sold under brands like Aspire, Ditropan, and Kentera, exhibited a 31% higher risk, while individuals taking tolterodine tartrate had a 27% increased risk. Researchers emphasized that not all anticholinergics carry
Common Bladder Medication May Increase Dementia Risk, Study Finds
Certain widely prescribed medications for overactive bladders may be linked to an increased chance of developing dementia, a new study suggests.
Concerns Over Common Treatment
The study, involving nearly 1 million people, found that some types of anticholinergic drugs were associated with an 18% increased risk of dementia diagnoses. It highlights a growing concern surrounding the safety and long-term effects of this common treatment method.